InfoNet Logo

 New Mexico AIDS InfoNet

Fact Sheet Number 425

ABACAVIR (Ziagen)


Eslabón a la Versión Español

 PrinterPrint

this Fact Sheet on a single page using:

 Microsoft Word

Adobe Acrobat

 More information on Downloading

& Printing Fact Sheets


WHAT IS ABACAVIR?

Abacavir (Ziagen®), is a drug used for antiviral therapy.

It is manufactured by GlaxoSmithKline. Abacavir used to be called

1592U89. The FDA approved abacavir late in 1998.

Abacavir is a type of drug called a nucleoside analog reverse

transcriptase inhibitor, or nuke. These drugs block the reverse

transcriptase enzyme. This enzyme changes HIV’s genetic material

(RNA) into the form of DNA. This has to occur before HIV’s genetic

code gets inserted into an infected cell’s own genetic codes.


WHO SHOULD TAKE

ABACAVIR?

Abacavir was approved as an antiviral drug for people with HIV

infection. There are no absolute rules about when to start antiviral

drugs. You and your doctor should consider your T-cell count,

your viral load, any symptoms you are having, and your attitude

about taking HIV medications. Fact

Sheet 411 has more information about guidelines

for the use of antiviral medications.

If you take abacavir with other antiviral drugs, you can reduce

your viral load to extremely low levels, and increase your T-cell

counts. This should mean staying healthier longer.

Abacavir seems to get into the central nervous system (spinal

fluid). Therefore, it may help prevent mental problems such as

dementia.


WHAT ABOUT DRUG

RESISTANCE?

Many new copies of HIV are mutations. They are slightly different

from the original virus. Some mutations can keep multiplying

even when you are taking an antiviral drug. When this happens,

the drug will stop working. This is called “developing resistance”

to the drug. See Fact Sheet 414

for more information on resistance.

Sometimes, if your virus develops resistance to one drug, it

will also have resistance to other antiviral drugs. This is called

“cross-resistance”.

Resistance can develop quickly. It is very important to

take antiviral medications according to instructions, on schedule,

and not to skip or reduce doses.

Abacavir appears to work even when HIV has some resistance

to other reverse transcriptase inhibitors.


HOW IS ABACAVIR

TAKEN?

Abacavir is taken by mouth as a capsule. The normal adult dose

is 300 milligrams (mg) two times a day. The capsules are 300mg,

so you will take 1 capsule at a time. Children take a liquid form.

The amount of liquid depends on the child’s body weight.

Abacavir can be taken with food, or between meals.

Abacavir is also available in Trizivir.

Trizivir contains AZT, 3TC, and abacavir. For more information,

see Fact Sheet 427 on Trizivir.


WHAT ARE THE SIDE

EFFECTS?

When you start any antiviral treatment, you may have temporary

side effects such as headaches, high blood pressure, or a general

sense of feeling ill. These side effects usually get better or

disappear over time. The most common side effects of abacavir

are headache, nausea and vomiting.


HYPERSENSITIVITY

REACTION

About 3-5% of people who take abacavir have an allergic reaction.

This usually develops within two weeks of starting abacavir. However,

it can appear up to six weeks or more after starting. Patients

had the following symptoms:

  • Fever (80% of patients)
  • Rash (60-70%)
  • Headache/feeling bad/no energy (60%)
  • Nausea, vomiting, diarrhea, or stomach pain (50%)
  • Cough, shortness of breath, or sore throat (20%)

If you have a hypersensitivity reaction, the symptoms will

get worse each time you take a dose and will not go away until

you stop taking the drug. If you develop any of these symptoms

while taking abacavir, call your doctor immediately. If you have

an allergic reaction to abacavir, stop taking it and do not start

again. A few allergic patients who re-started abacavir had

life-threatening reactions.

If you ever stopped abacavir for any reason (for example,

because you ran out), talk to your doctor before you start

again. In rare cases, people who thought they weren’t allergic

had serious reactions when re-starting abacavir.


HOW DOES ABACAVIR

REACT WITH OTHER DRUGS?

Abacavir is intended to be used along with other antiviral drugs.

No specific interactions with other antiviral drugs have been

identified yet.

Although most reverse transcriptase inhibitors are used along

with a protease inhibitor, Abacavir has been tested in combination

with two other reverse transcriptase inhibitors. The results were

almost as good as combinations that include a protease inhibitor.

Abacavir works better if it is taken with the protease

inhibitor amprenavir.


Revised February 7, 2002

HomeGo

to InfoNet Main Page

Card FileGo to

Index of Fact Sheets

Question markClick

here if you have questions

The New Mexico AIDS InfoNet is a project of the

New Mexico AIDS Education and Training Center

Partially funded by the National Library of Medicine

and the New Mexico Department of Health